Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and RecurrenceTheodore M. Brasky, Louise A. Brinton, Christa Nagel et al.|JNCI Journal of the National Cancer Institute|2016Cited by 57
Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 StudyAshley S. Felix, Louise A. Brinton, Theodore M. Brasky et al.|International Journal of Cancer|2017Cited by 34
Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 StudyAshley S. Felix, Louise A. Brinton, David E. Cohn et al.|American Journal of Obstetrics and Gynecology|2018Cited by 16
Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and RecurrenceOlga B. Ioffe, Christa Nagel, Kay J. Park et al.|UNC Libraries|2020Cited by 2
Abstract C44: Endometrial carcinoma recurrence in black and white women in the NRG Oncology/Gynecologic Oncology Group 210 trialAshley S. Felix, Louise A. Brinton, Theodore M. Brasky et al.|Cancer Epidemiology Biomarkers & Prevention|2017Cited by 1